Brief: Interpace Biosciences Enters Into Agreement For $20 Mln Investment

Interpace Biosciences

13/01/2020 12:36

Jan 13 (Reuters) - Interpace Biosciences Inc  IDXG.O :
    * INTERPACE BIOSCIENCES ENTERS INTO AGREEMENT FOR $20
MILLION
INVESTMENT FROM 1315 CAPITAL AND AMPERSAND CAPITAL PARTNERS
    * INTERPACE BIOSCIENCES INC - ENTERED INTO AN AGREEMENT FOR
A NEW
SERIES B PREFERRED STOCK INVESTMENT OF $20 MILLION
    * INTERPACE BIOSCIENCES -INTENDS TO EFFECT ONE-FOR-TEN
REVERSE
STOCK SPLIT EFFECTIVE COINCIDENT WITH CLOSING OF NEW SERIES B
PREFERRED STOCK INVESTMENT
    * INTERPACE BIOSCIENCES INC - NEW SERIES B PREFERRED STOCK
INVESTMENT WILL BE CONVERTIBLE INTO COMMON STOCK AT A CONVERSION
PRICE OF $0.60

Source text for Eikon:  ID:nGNX9ym2Y7 
Further company coverage:  IDXG.O 

 ((Reuters.Briefs@thomsonreuters.com;))